Imaging: Any
method used to produce a picture of internal body structures. Some imaging methods used to
detect cancer are x-rays (a breast x-ray is called a mammogram), magnetic resonance (MR)
imaging, scintigraphy, computed tomography (CT) imaging, and ultrasonography. (See also mammogram, bone scan, computed
tomography, magnetic resonance imaging, ultrasonography).
Immune system: The complex system by which the
body resists infection by microbes (such as bacteria or viruses) and rejects transplanted
tissues or organs. The immune system may also help the body fight some cancers. (See also antibody, antigen, lymph nodes).
Immunocytochemistry
or immunohistochemistry: A laboratory
test that uses antibodies to detect specific chemical antigens in cells or tissue samples
viewed under a microscope. This procedure can be used to help detect and classify cancer
cells. It is also one of the methods used for estrogen receptor assays and progesterone
receptor assays. (See also monoclonal
antibodies).
Immunology: Study of how the body resists
infection and certain other diseases. Knowledge gained in this field is important to
cancer treatments based on the principles of immunology. (See also immunotherapy).
Immunosuppression: A state in which the ability of
the bodys immune system to respond is decreased. This condition may be present at
birth, may be caused by certain infections (such as human immunodeficiency virus or HIV),
or by certain cancer therapies, such as cytotoxic (cancer-cell killing) drugs, radiation,
and bone marrow transplant action.
Immunotherapy: Treatments that promote or support
the bodys immune system response to a disease, such as cancer.
Incisional biopsy: The
removal of part of a lump for microscopic (pathologic) examination. (See also biopsy).
Infiltrating ductal carcinoma (IDC): Cancer
beginning in the milk ducts of the breast and penetrating the wall of the duct, invading
the fatty tissue of the breast and possibly other regions of the body. IDC is the most
common type of breast cancer, accounting for 80% of breast cancer diagnoses. Also called invasive ductal carcinoma.
Infiltrating lobular carcinoma (ILC):
Cancer beginning in the milk glands (lobules) of the breast, but often spreading to
other regions of the body. ILC accounts for 10% to 15% of breast cancers. Also called invasive lobular carcinoma.
Inflammatory carcinoma: The appearance of inflamed
breasts (red and warm) with dimples and/or ridges caused by the infiltration of tumor
cells into the lymphatics.
Infraclavicular nodes: Lymph nodes located beneath
the clavicle (collar bone).
Inframammary fold: The lower breast fold that
attaches the lowest portion of the breast to the rib cage.
Infusion: The slow intravenous (through the vein)
delivery of drugs or fluids.
Injection: The use of a syringe and needle to push
fluids or drugs into the body. Also called
shot.
In situ: Literally meaning, in place. The term, in situ, applies to cancer that is
within the original tissue and has not yet broken through any boundaries between tissues.
(See also ductal carcinoma in situ, lobular
carcinoma in situ).
Interferon: A protein produced by cells,
interferon helps regulate the bodys immune system, boosting activity when a threat,
such as a virus, is detected. Scientists have learned that interferon helps fight against
cancer, so it is used for immunotherapy of some types of cancer.
Internal
mammary nodes: Lymph nodes
beneath the breast bone on each side. Some breast cancers may spread to these nodes.
Intraductal
papilloma: Small, finger-like, polyp-like, noncancerous growths in the breast
ducts that may cause a bloody nipple discharge. These are most often found in women 45 to
50 years of age. When many papillomas exist, breast cancer risk is slightly increased.
Intravenous (IV): A method of supplying fluids and
medications, using a needle inserted in a vein.
Invasive
cancer: Cancer that has spread beyond the area it originally developed in, to
involve adjacent tissues. For example, invasive breast cancers develop in milk glands
(lobules) or milk passages (ducts) and spread to the adjacent fatty breast tissue. Some
invasive cancers spread to distant areas of the body (metastasize), but others do not.
Also called infiltrating cancer. (See also
invasive ductal carcinoma, invasive lobular carcinoma).
Invasive ductal carcinoma: A
cancer that originates in the milk passages (ducts) of the breast and then breaks through
the duct wall, where it invades the fatty tissue of the breast. When it reaches this
point, it has the potential to spread (metastasize) elsewhere in the breast, as well as to
other parts of the body through the bloodstream and lymphatic system. Invasive ductal
carcinoma is the most common type of breast cancer, accounting for about 80% of breast
malignancies. Also known as infiltrating ductal carcinoma.
Invasive lobular carcinoma:
A cancer that arises in the milk-producing glands (lobules) of the breast and then breaks
through the lobule walls to involve the adjacent fatty tissue. From this site, it may then
spread elsewhere in the breast. About 15% of invasive breast cancers are invasive lobular
carcinomas. It is often difficult to detect by physical examination or even by
mammography. Also called infiltrating lobular carcinoma.
Inverted nipple: A condition in which the nipple
is tucked into the areola (pigmented region surrounding the areola).
Involved
margins: Term used to describe breast cancer that extends beyond the surgical margin
of removal. This condition indicates that additional cancer is still present in the
breast.
Updated: August 2006
|